Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 4
1962 8
1963 11
1964 9
1965 7
1966 11
1967 6
1968 10
1969 9
1970 14
1971 22
1972 22
1973 11
1974 15
1975 13
1976 11
1977 6
1978 13
1979 14
1980 18
1981 17
1982 11
1983 17
1984 26
1985 20
1986 28
1987 31
1988 23
1989 32
1990 35
1991 41
1992 40
1993 31
1994 34
1995 45
1996 34
1997 32
1998 26
1999 28
2000 29
2001 34
2002 43
2003 49
2004 38
2005 38
2006 41
2007 45
2008 37
2009 43
2010 69
2011 54
2012 53
2013 54
2014 57
2015 56
2016 59
2017 51
2018 57
2019 49
2020 38
2021 35
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,699 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Mustian KM, et al. JAMA Oncol. 2017 Jul 1;3(7):961-968. doi: 10.1001/jamaoncol.2016.6914. JAMA Oncol. 2017. PMID: 28253393 Free PMC article. Review.
IMPORTANCE: Cancer-related fatigue (CRF) remains one of the most prevalent and troublesome adverse events experienced by patients with cancer during and after therapy. ...Results suggest that the effectiveness of behavioral interventions, specifically exercise and p …
IMPORTANCE: Cancer-related fatigue (CRF) remains one of the most prevalent and troublesome adverse events experienced by patients wit …
Blocking PPARgamma interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.
Yang PB, Hou PP, Liu FY, Hong WB, Chen HZ, Sun XY, Li P, Zhang Y, Ju CY, Luo LJ, Wu SF, Zhou JX, Wang ZJ, He JP, Li L, Zhao TJ, Deng X, Lin T, Wu Q. Yang PB, et al. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27412-27422. doi: 10.1073/pnas.2002997117. Epub 2020 Oct 21. Proc Natl Acad Sci U S A. 2020. PMID: 33087562 Free PMC article.
Mechanistically, Nur77 interacted and recruited corepressors, the SWI/SNF complex, to the promoters of CD36 and FABP4 to suppress their transcriptions, which hampered the fatty acid uptake, leading to the inhibition of cell proliferation. Peroxisome proliferator-activated …
Mechanistically, Nur77 interacted and recruited corepressors, the SWI/SNF complex, to the promoters of CD36 and FABP4 to suppress their tran …
Psychostimulants for cancer-related fatigue.
Breitbart W, Alici Y. Breitbart W, et al. J Natl Compr Canc Netw. 2010 Aug;8(8):933-42. doi: 10.6004/jnccn.2010.0068. J Natl Compr Canc Netw. 2010. PMID: 20870637 Review.
Fatigue is a highly prevalent and distressing symptom associated with significant psychological and functional morbidity and decreased quality of life among patients with cancer. Despite its impact on patients and caregivers, fatigue is underreported and underrecognized, a …
Fatigue is a highly prevalent and distressing symptom associated with significant psychological and functional morbidity and decreased quali …
Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
Guan YF, Huang QL, Ai YL, Chen QT, Zhao WX, Wang XM, Wu Q, Chen HZ. Guan YF, et al. Oncogene. 2020 Mar;39(11):2408-2423. doi: 10.1038/s41388-020-1158-y. Epub 2020 Jan 20. Oncogene. 2020. PMID: 31959898 Free PMC article.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Orphan nuclear receptor Nur77, which is low expressed in HCC, functions as a tumor suppressor to suppress HCC. ...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Orphan nuclear receptor Nur77, whi …
The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review.
Andrew BN, Guan NC, Jaafar NRN. Andrew BN, et al. Curr Drug Targets. 2018;19(8):877-887. doi: 10.2174/1389450118666170317162603. Curr Drug Targets. 2018. PMID: 28322161 Review.
BACKGROUND: One of the goals of cancer treatment is symptoms management especially at the end stage. The common symptoms in cancer include pain, fatigue, depression and cognitive dysfunction. ...
BACKGROUND: One of the goals of cancer treatment is symptoms management especially at the end stage. The common symptoms in cancer
The use of psychostimulants in cancer patients.
Portela MA, Rubiales AS, Centeno C. Portela MA, et al. Curr Opin Support Palliat Care. 2011 Jun;5(2):164-8. doi: 10.1097/SPC.0b013e3283462ff3. Curr Opin Support Palliat Care. 2011. PMID: 21532350 Review.
Initial studies mainly investigated the treatment of depressive symptoms in patients with advanced cancer; however, more recent studies have evaluated the use of psychostimulants in cancer-related fatigue identifying subgroups of patients and clinical settings in wh …
Initial studies mainly investigated the treatment of depressive symptoms in patients with advanced cancer; however, more recent studi …
Update on psychotropic medications for cancer-related fatigue.
Breitbart W, Alici-Evcimen Y. Breitbart W, et al. J Natl Compr Canc Netw. 2007 Nov;5(10):1081-91. doi: 10.6004/jnccn.2007.0089. J Natl Compr Canc Netw. 2007. PMID: 18053430 Review.
The reported prevalence of cancer-related fatigue ranges from 4% to 91%, depending on the specific cancer population studied and the methods of assessment. Cancer-related fatigue has typically been underreported, underdiagnosed, and undertreated. ...
The reported prevalence of cancer-related fatigue ranges from 4% to 91%, depending on the specific cancer population studied a …
Cytosporone B is an agonist for nuclear orphan receptor Nur77.
Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D, Li G, Xu Q, Zhang M, Weimer BC, Chen D, Cheng Z, Zhang L, Li Q, Li S, Zheng Z, Song S, Huang Y, Ye Z, Su W, Lin SC, Shen Y, Wu Q. Zhan Y, et al. Nat Chem Biol. 2008 Sep;4(9):548-56. doi: 10.1038/nchembio.106. Nat Chem Biol. 2008. PMID: 18690216 Free article.
Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release. Thus, Csn-B may represent a promising therapeutic drug for cancers and hypoglycemia, and it may also be us …
Moreover, Csn-B induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to c …
Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis.
Qu D, Zhang Z, Yu X, Zhao J, Qiu F, Huang J. Qu D, et al. Eur J Cancer Care (Engl). 2016 Nov;25(6):970-979. doi: 10.1111/ecc.12397. Epub 2015 Oct 21. Eur J Cancer Care (Engl). 2016. PMID: 26490083 Review.
Cancer-related fatigue (CRF) is a common symptom affecting 60-90% of cancer survivors, and effective management for CRF is not yet available. ...
Cancer-related fatigue (CRF) is a common symptom affecting 60-90% of cancer survivors, and effective management for CRF is not
1,699 results